AIM Vaccine Co., Ltd. Class H (HK:6660) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
AIM Vaccine Co., Ltd. hosted its 2024 Corporate Day event, attracting significant interest from securities firms and institutional investors. The company showcased its innovative vaccine pipeline, including the highly anticipated 13-valent pneumonia conjugate and mRNA shingles vaccines. AIM Vaccine aims to lead the market with its cutting-edge rabies vaccines, leveraging advanced technology and strategic marketing to expand its market share.
For further insights into HK:6660 stock, check out TipRanks’ Stock Analysis page.